BioTech Receives Its First Impact Factor of 2.7

We are pleased to share that BioTech (ISSN: 2673-6284) has received its first Impact Factor of 2.7 in the Journal Citation Reports™ (Clarivate) in June 2024, as a result of being indexed in the Emerging Sources Citation Index (ESCI) within the Web of Science Core Collection.

The 2023 Journal Impact Factor is calculated by dividing the number of citations received in 2023 to all publications in the journal from 2021 and 2022 by the total number of citable publications from those same years. For further statistics, please visit https://www.mdpi.com/journal/biotech/stats. For more information about MDPI flagship journals' citation metrics, please see here.

The support and dedication of all the editors, reviewers, authors, and readers are an integral part of the journal’s performance. We would like to take this opportunity to thank all of you who have contributed to the journal.

Our journals have received over 13 million citations in the Web of Science, making us the most cited open access publisher. With over 800 institutional partners, MDPI continues to demonstrate its dedication to providing reliable and collaborative publishing services.

BioTech Editorial Office